Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

The only actual available "test" for Alzheimer’s disease in younger people would be to check someone's APOE 4 levels, which ...

Guwahati: In a significant advancement for yak genomic science, the first-ever chromosome-level genome of the Indian yak (Bos ...

First-ever chromosome-level genome of the Indian yak revolutionizes breeding, conservation, and understanding of this vital ...

During a live event, Shuo Ma, MD, PhD, discussed the resistance mutation analysis of patients who had disease progression ...

Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to ...

Experts have discovered that prolonged periods of sitting or lying down could heighten the risk of dementia. A recent study ...

A new study has found that spending too much time sitting down could increase your risk of dementia, no matter how often you ...

A recent study has found that increased sedentary behavior—spending extended periods sitting or lying down—is associated with ...